Preventive pharmacotherapy in type 2 diabetes mellitus
Open Access
- 1 January 2012
- journal article
- review article
- Published by Medknow in Indian Journal of Endocrinology and Metabolism
- Vol. 16 (1), 33-43
- https://doi.org/10.4103/2230-8210.91183
Abstract
Over the last few decades certain demographic changes have been observed worldwide, which have led to an increase in the prevalence of chronic non-communicable diseases. Type 2 diabetes mellitus and associated cardiovascular disease are major contributors to this disease burden leading to rising morbidity and mortality. It is worrisome to see that type 2 diabetes with its micro- and macrovascular complications is occurring in younger populations where it was hitherto unseen. Prevention appears to be an important strategy to reduce the burden of disease. Along with inculcating healthy lifestyle habits across populations, it may be suitable to use preventive pharmacotherapy in those with pre-diabetes and / or other risk factors like obesity, hypertension, and on the like. Metformin, alpha glucosidase inhibitors like acarbose, miglitol, and voglibose, and pioglitazone have all been used with success. The issues of compliance and adverse effects during long-term use have tempered the use of these drugs. The best approach would be to motivate the patient for effective lifestyle changes, and pharmacological management if the lifestyle changes are not successful in achieving their goals.Keywords
This publication has 60 references indexed in Scilit:
- Serum 25-Hydroxyvitamin D Levels and Prediabetes Among Subjects Free of DiabetesDiabetes Care, 2011
- Standards of Medical Care in Diabetes—2011Diabetes Care, 2011
- Obesity, Diabetes, and Gut MicrobiotaDiabetes Care, 2010
- Effects of Exenatide and Lifestyle Modification on Body Weight and Glucose Tolerance in Obese Subjects With and Without Pre-DiabetesDiabetes Care, 2010
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trialsThe Lancet, 2010
- Familial Risks for Type 2 Diabetes in SwedenDiabetes Care, 2009
- From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes MellitusDiabetes, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinThe New England Journal of Medicine, 2008
- Telmisartan to Prevent Recurrent Stroke and Cardiovascular EventsThe New England Journal of Medicine, 2008
- Global and societal implications of the diabetes epidemicNature, 2001